Q3 2024 Evolent Health Inc Earnings Call Transcript
Key Points
- Evolent Health Inc (EVH) announced six new revenue agreements in the third quarter, marking the highest number of new agreements in a single quarter since the company's founding.
- The company is well-capitalized and cash flow positive, with a strong liquidity profile, generating $312 million in cash from operations over the last eight quarters.
- Evolent Health Inc (EVH) has secured $250 million in incremental committed financing, providing a buffer for potential slower cash receipts and a proactive path for 2025 convertible note maturity.
- The company reaffirmed its long-term expectations for revenue growth of 15% and adjusted EBITDA growth of at least 20% on average annually.
- Evolent Health Inc (EVH) continues to see strong demand for its specialty solutions, with significant new business signings and a robust sales pipeline going into 2025.
- Evolent Health Inc (EVH) revised its 2024 adjusted EBITDA outlook downward due to higher than expected medical costs, particularly in its specialty performance suite.
- The company experienced a significant spike in oncology costs, driven by factors such as increased disease prevalence and rapid increases in unit costs.
- Evolent Health Inc (EVH) is facing challenges with reimbursement rates, necessitating negotiations for an additional $100 million in annualized rate increases.
- The company's accounts receivable collections have slowed, prompting a draw on its revolving credit facility.
- Evolent Health Inc (EVH) is dealing with a small number of partners driving high medical loss ratios, representing 40-50% of performance suite revenue, which may require exiting risk arrangements if terms cannot be aligned.
Welcome to the Evelyn earnings conference call for the third quarter ended September 30th 2024. As a reminder, this conference call is being recorded. Your hosts for the call today from Evelyn are Seth Blackley, Chief Executive Officer and John Johnson, Chief Financial Officer. This call will be archived and available later this evening and for the rest of the week via the webcast on the company's website in the section titled Investor Relations.
I will now hand the call over to Seth Frank Evelyn's Vice President of Investor Relations.
Thank you and good evening. This conference call will contain forward-looking statements under the US federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports that are filed with the securities and exchange commission including cautionary statements included in our current
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
